enableCV, LLC

enableCV, LLC is an independent cardiac surgery device company focused on advancing minimally invasive and open-heart surgical procedures. The company develops innovative medical devices designed to provide continuous blood flow during cardiopulmonary bypass and enable next-generation cardiac surgery techniques. EnableCV's product portfolio includes the IntraClude intra-aortic occlusion device for minimally invasive cardiac procedures, the ProPlege peripheral retrograde cardioplegia device for coronary sinus occlusion and cardioplegia delivery, the QuickDraw Plus femoral venous cannula for blood drainage during bypass, and arterial cannulae (OptiSite and EZ Glide) for short-term perfusion. The company leverages deep expertise developed through its heritage with Edwards Lifesciences and collaborates with a preeminent medical advisory board to expand its portfolio. All devices are FDA-regulated and restricted to sale by or on the order of a physician. EnableCV serves cardiac surgeons and cardiothoracic surgical centers requiring specialized bypass and cardioplegia management solutions.